Pharmacokinetic Allometric Scaling of Oligonucleotides

被引：10
|
作者：
Mahmood, Iftekhar [1 ]
机构：
[1] US FDA, Off Blood Review & Res OBRR, Ctr Biol Evaluat & Res, Rockville, MD USA
来源：
NUCLEIC ACID THERAPEUTICS | 2011年 / 21卷 / 05期
关键词：
HUMAN DRUG CLEARANCE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE GEM-91; MODIFIED ANTISENSE OLIGONUCLEOTIDE; NECROSIS-FACTOR-ALPHA; PHASE-I TRIAL; INTRAVENOUS-INFUSION; PREDICTION; HUMANS; BCL-2; METABOLISM;
D O I：
10.1089/nat.2011.0299
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The objective of this study was to evaluate the predictive performance of interspecies scaling of oligonucleotides to predict clearance and volume of distribution at steady state in humans from animal data. The human pharmacokinetic parameters were predicted using 1, 2, or at least 3 animal species. The results of the study indicated that the pharmacokinetic parameters of oligonucleotides can be predicted with reasonable accuracy in humans when at least 3 animal species are employed. On the other hand, allometric scaling based on 1 or 2 species or fixed coefficient or fixed exponent can be erratic and unreliable. Further work should be conducted in this direction.
引用
收藏
页码：315 / 321
页数：7
相关论文
共 50 条
  • [41] Differentiating causality and correlation in allometric scaling: ant colony size drives metabolic hypometry
    Waters, James S.
    Ochs, Alison
    Fewell, Jennifer H.
    Harrison, Jon F.
    PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2017, 284 (1849)
  • [42] Approaches for Predicting Human Pharmacokinetics Using Interspecies Pharmacokinetic Scaling
    Kang, Hee Eun
    Lee, Myung Gull
    ARCHIVES OF PHARMACAL RESEARCH, 2011, 34 (11) : 1779 - 1788
  • [43] A Bodyweight-Dependent Allometric Exponent for Scaling Clearance Across the Human Life-Span
    Wang, Chenguang
    Peeters, Mariska Y. M.
    Allegaert, Karel
    van Oud-Alblas, Heleen J. Blusse
    Krekels, Elke H. J.
    Tibboel, Dick
    Danhof, Meindert
    Knibbe, Catherijne A. J.
    PHARMACEUTICAL RESEARCH, 2012, 29 (06) : 1570 - 1581
  • [44] Is allometric scaling really a panacea for flow-mediated dilation? Commentary on paper by Atkinson and Batterham
    Stoner, Lee
    Faulkner, James
    Sabatier, Manning J.
    ATHEROSCLEROSIS, 2013, 228 (01) : 280 - 281
  • [45] Contrasting toxicokinetic evaluations and interspecies pharmacokinetic scaling approaches for small molecules and biologics: applicability to biosimilar development
    Offman, Elliot
    Edginton, Andrea N.
    XENOBIOTICA, 2013, 43 (06) : 561 - 569
  • [46] Toxicokinetics of bisphenol S in rats for predicting human bisphenol S clearance from allometric scaling
    Gayrard, Veronique
    Lacroix, Marlene Z.
    Gely, Clemence A.
    Grandin, Flore C.
    Leandri, Roger
    Bouchard, Michele
    Roques, Beatrice
    Toutain, Pierre-Louis
    Picard-Hagen, Nicole
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2020, 386
  • [47] Quantitative prediction of human pharmacokinetics and pharmacodynamics of imigliptin, a novel DPP-4 inhibitor, using allometric scaling, IVIVE and PK/PD modeling methods
    Liu, Dongyang
    Ma, Xifeng
    Liu, Yang
    Zhou, Huimin
    Shi, Chongtie
    Wu, Frank
    Jiang, Ji
    Hu, Pei
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 89 : 73 - 82
  • [48] An Update on the Use of Allometric and Other Scaling Methods to Scale Drug Clearance in Children: Towards Decision Tables
    van Rongen, Anne
    Krekels, Elke H. J.
    Calvier, Elisa A. M.
    de Wildt, Saskia N.
    Vermeulen, An
    Knibbe, Catherijne A. J.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2022, 18 (02) : 99 - 113
  • [49] Prediction of a potentially effective dose in humans for BAY 60-5521, a potent inhibitor of cholesteryl ester transfer protein (CETP) by allometric species scaling and combined pharmacodynamic and physiologically-based pharmacokinetic modelling
    Weber, Olaf
    Willmann, Stefan
    Bischoff, Hilmar
    Li, Volkhart
    Vakalopoulos, Alexandros
    Lustig, Klemens
    Hafner, Frank-Thorsten
    Heinig, Roland
    Schmeck, Carsten
    Buehner, Klaus
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (02) : 219 - 231
  • [50] Across-species meta-analysis of dexamethasone pharmacokinetics utilizing allometric and scaling modeling approaches
    Song, Dawei
    Jusko, William J.
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2021, 42 (05) : 191 - 203
12345